NasdaqGS:OMCLMedical Equipment
Does Omnicell’s Profit Squeeze Amid Higher Sales and 2026 Outlook Change The Bull Case For OMCL?
In early February 2026, Omnicell, Inc. reported fourth-quarter 2025 revenue of US$313.98 million and a quarterly net loss of US$2.03 million, while issuing first-quarter 2026 revenue guidance of US$300 million to US$310 million and full-year 2026 guidance of US$1.22 billion to US$1.26 billion.
Although Omnicell grew full-year 2025 revenue to US$1.18 billion from US$1.11 billion, net income shrank to US$2.05 million, highlighting pressure on profitability despite higher sales.
Now we’ll...